PD-L2

GPTKB entity

Statements (68)
Predicate Object
gptkbp:instance_of gptkb:protein
gptkbp:associated_with tumor immune evasion
gptkbp:community immune responses
gptkbp:function immune checkpoint
gptkbp:has_influence_on therapeutic outcomes
gptkbp:has_role tumor microenvironment
autoimmunity
cancer immunotherapy
https://www.w3.org/2000/01/rdf-schema#label PD-L2
gptkbp:initiated_by T cell activation
immune checkpoint inhibitors
gptkbp:interacts_with gptkb:PD-1
gptkbp:involved_in immune response
regulation of immune system
gptkbp:is_associated_with disease progression
regulatory T cells
poor prognosis in cancer
tumor microenvironment remodeling
gptkbp:is_expressed_in gptkb:myeloid-derived_suppressor_cells
gptkb:tumor_infiltrating_lymphocytes
gptkb:Cell
inflammation
macrophages
lymphoid tissues
dendritic cells
solid tumors
cancer stem cells
tumor cells
hematopoietic cells
neoplastic tissues
tumor-associated macrophages
cancer-associated fibroblasts
lymphatic tissues
peripheral blood mononuclear cells
gptkbp:is_found_in human tissues
gptkbp:is_involved_in immune evasion mechanisms
adaptive immunity
tumor progression
immune response modulation
immune checkpoint blockade
tumor immune interactions
immune cell regulation
cancer metastasis
immune surveillance
cancer immunoediting
cancer therapy resistance
tumor escape mechanisms
immune checkpoint therapy
T cell exhaustion
T cell tolerance
cancer immunotherapy strategies
immune checkpoint signaling
tumor immune microenvironment
gptkbp:is_linked_to immune tolerance
chronic inflammation
chronic infections
gptkbp:is_part_of immune checkpoint pathways
gptkbp:is_regulated_by transcription factors
cytokines
gptkbp:is_studied_in cancer research
gptkbp:is_targeted_at clinical trials
monoclonal antibodies
gptkbp:knockouts PD-1 receptor
gptkbp:located_in cell membrane
gptkbp:promoter PDCD1 LG2
gptkbp:related_to PD-1 pathway
gptkbp:bfsParent gptkb:PD-1
gptkbp:bfsLayer 6